Across TCGA pan-cancer cohorts, KIAA1586 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated KIAA1586 data layer compared with 26 for mass-spec protein and 7 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher KIAA1586 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated KIAA1586 expression acts as an unfavorable survival marker, although some lineages such as UCEC and GBM show a favorable association.
UCEC and GBM are the cancer types where KIAA1586 mass-spec protein most reproducibly stratifies survival.